Literature DB >> 30945513

Regional analgesia techniques for pain management in patients admitted to the intensive care unit.

Ruben Rubio-Haro1, Javier Morales-Sarabia1, Carolina Ferrer-Gomez1, José de Andres2.   

Abstract

Controlling pain should be a priority in the clinical practice of intensive care units (ICUs). Monomodal analgesic approaches, such as the administration of opioids, are widely employed; however, the widespread use of opioids has catastrophic consequences, given their multiple side effects and the development of dependence. Regional analgesia (RA), with single or continuous dosing using neuraxial and peripheral catheters, can play an important role in multimodal analgesia for management of pain in critical care patients. RA provides superior pain control, as compared to systemic treatments, and is associated with a lower rate of side effects. Nevertheless, RA remains underused in ICUs. Many critically ill, post-surgical or traumatically injured patients would benefit from these techniques. For these reasons, we aim to establish a set of potential indications integrating the use of RA in analgesia protocols routinely used in ICUs. We performed a review of literature sources with contrasted evidence levels to present RA techniques and their potential applications in ICU patients.

Entities:  

Year:  2019        PMID: 30945513     DOI: 10.23736/S0375-9393.19.13447-5

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  2 in total

Review 1.  Perioperative Pain Management and Opioid Stewardship: A Practical Guide.

Authors:  Sara J Hyland; Kara K Brockhaus; William R Vincent; Nicole Z Spence; Michelle M Lucki; Michael J Howkins; Robert K Cleary
Journal:  Healthcare (Basel)       Date:  2021-03-16

2.  Meralgia paresthetica after pelvic fixation in a polytrauma patient.

Authors:  Pablo Kot; Ruben Rubio-Haro; Clara Bordes-García; Carolina Ferrer-Gómez; Jose De Andrés
Journal:  Korean J Anesthesiol       Date:  2021-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.